AAAAAA

   
Results: 1-25 | 26-50
Results: 1-25/50
OROPHARYNGEAL CANDIDIASIS AS A MARKER FOR ESOPHAGEAL CANDIDIASIS IN PATIENTS WITH CANCER
Authors: SAMONIS G SKORDILIS P MARAKI S DATSERIS G TOLOUDIS P CHATZINIKOLAOU I GEORGOULIAS V BODEY G
Citation: G. Samonis et al., OROPHARYNGEAL CANDIDIASIS AS A MARKER FOR ESOPHAGEAL CANDIDIASIS IN PATIENTS WITH CANCER, Clinical infectious diseases, 27(2), 1998, pp. 283-286
WEEKLY DOCETAXEL AND CONCOMITANT BOOST RADIOTHERAPY FOR NONSMALL CELLLUNG-CANCER - A PHASE I II DOSE-ESCALATION TRIAL/
Authors: KOUKOURAKIS MI KOUROUSIS C KAMILAKI M KOUKOURAKI S GIATROMANOLAKI A KAKOLYRIS S KOTSAKIS A ANDROULAKIS N BAHLITZANAKIS N GEORGOULIAS V
Citation: Mi. Koukourakis et al., WEEKLY DOCETAXEL AND CONCOMITANT BOOST RADIOTHERAPY FOR NONSMALL CELLLUNG-CANCER - A PHASE I II DOSE-ESCALATION TRIAL/, European journal of cancer, 34(6), 1998, pp. 838-844
HUMAN AP ENDONUCLEASE-1 (HAP1) NUCLEAR EXPRESSION CORRELATES WITH SURVIVAL IN OPERABLE NONSMALL CELL LUNG-CANCER
Authors: KAKOLYRIS S GIATROMANOLAKI A KOUKOURAKIS MI GEORGOULIAS V GATTER KC HARRIS AL
Citation: S. Kakolyris et al., HUMAN AP ENDONUCLEASE-1 (HAP1) NUCLEAR EXPRESSION CORRELATES WITH SURVIVAL IN OPERABLE NONSMALL CELL LUNG-CANCER, European journal of cancer, 34, 1998, pp. 133-133
CONCURRENT WEEKLY DOCETAXEL AND RADIOTHERAPY FOR NONSMALL CELL LUNG-CANCER - A PHASE-I AND PHASE-II TRIAL WITH IMMUNOLOGICAL TOXICITY EVALUATION
Authors: KOUKOURAKIS MI GIATROMANOLAKI A KAKOLYRIS S GEORGOULIAS V
Citation: Mi. Koukourakis et al., CONCURRENT WEEKLY DOCETAXEL AND RADIOTHERAPY FOR NONSMALL CELL LUNG-CANCER - A PHASE-I AND PHASE-II TRIAL WITH IMMUNOLOGICAL TOXICITY EVALUATION, European journal of cancer, 34, 1998, pp. 135-135
P53, BCL-2 AND RESPONSE OF LOCALLY ADVANCED SQUAMOUS-CELL HEAD AND NECK-CANCER TO PLATINUM-BASED CHEMOTHERAPY AND CHEMORADIOTHERAPY
Authors: GIATROMANOLAKI A KOUKOURAKIS ML KAKOLYRIS S GEORGOULIAS V FUNTZILAS G
Citation: A. Giatromanolaki et al., P53, BCL-2 AND RESPONSE OF LOCALLY ADVANCED SQUAMOUS-CELL HEAD AND NECK-CANCER TO PLATINUM-BASED CHEMOTHERAPY AND CHEMORADIOTHERAPY, European journal of cancer, 34, 1998, pp. 148-148
SALVAGE CHEMOTHERAPY OF METASTATIC BREAST-CANCER WITH DOCETAXEL AND GEMCITABINE - A MULTICENTER PHASE-II TRIAL
Authors: MAVROUDIS D MALAMOS N GIANNAKAKIS T ALEXOPOULOS A POTAMIANOU A RIGATOS G KOSMAS C SARRA E PAPADOURIS S GEORGOULIAS V
Citation: D. Mavroudis et al., SALVAGE CHEMOTHERAPY OF METASTATIC BREAST-CANCER WITH DOCETAXEL AND GEMCITABINE - A MULTICENTER PHASE-II TRIAL, Annals of oncology, 9, 1998, pp. 90-90
PHASE-I STUDY OF DOCETAXEL AND EPIRUBICIN IN ADVANCED BREAST-CANCER
Authors: PANAGOS G MAVROUDIS D POTAMIANOU A MALAMOS N KOUROUSIS C KAKOLYRIS S SOUGLAKOS J SARRA E GIANNAKAKIS T GEORGOULIAS V
Citation: G. Panagos et al., PHASE-I STUDY OF DOCETAXEL AND EPIRUBICIN IN ADVANCED BREAST-CANCER, Annals of oncology, 9, 1998, pp. 97-97
TREATMENT OF METASTATIC BREAST-CANCER WITH INTENSIFIED COMBINATION OFDOCETAXEL AND MITOXANTRONE - A MULTICENTER PHASE-II TRIAL
Authors: ALEXOPOULOS A MALAMOS N GIANNAKAKIS T MAUROUDIS D PANAGOS G AGELAKI S KOSMAS C SOUGLAKOS J VARDAKIS N APOSTOLAKI F GEORGOULIAS V
Citation: A. Alexopoulos et al., TREATMENT OF METASTATIC BREAST-CANCER WITH INTENSIFIED COMBINATION OFDOCETAXEL AND MITOXANTRONE - A MULTICENTER PHASE-II TRIAL, Annals of oncology, 9, 1998, pp. 127-127
2ND LINE TREATMENT OF METASTATIC COLON CARCINOMAS WITH OXALIPLATIN AND HIGH-DOSE 5-FLUOROURACIL AND FOLINIC ACID - A PRELIMINARY-REPORT OF A CONFIRMATORY PHASE-II TRIAL OF THE GREEK COOPERATIVE GROUP FOR THE STUDY OF COLORECTAL-CANCER
Authors: ZIRAS N GIANAKAKIS T ANDROULAKIS N MAVROUDIS D KAKOLYRIS S TSITOURA P KOUROUSIS C SOUGLAKOS J PERISINAKI G GEORGOULIAS V
Citation: N. Ziras et al., 2ND LINE TREATMENT OF METASTATIC COLON CARCINOMAS WITH OXALIPLATIN AND HIGH-DOSE 5-FLUOROURACIL AND FOLINIC ACID - A PRELIMINARY-REPORT OF A CONFIRMATORY PHASE-II TRIAL OF THE GREEK COOPERATIVE GROUP FOR THE STUDY OF COLORECTAL-CANCER, Annals of oncology, 9, 1998, pp. 208-208
TREATMENT OF PANCREATIC-CANCER WITH DOCETAXEL AND GRANULOCYTE-COLONY-STIMULATING FACTOR - A MULTICENTER PHASE-II STUDY
Authors: ANDROULAKIS N KOUROUSIS C DIMOPOULOS AM SAMELIS G TSAVARIS N GENATAS K PANAGOS G ARAVANTINOS G STATHOPOULOS G GEORGOULIAS V
Citation: N. Androulakis et al., TREATMENT OF PANCREATIC-CANCER WITH DOCETAXEL AND GRANULOCYTE-COLONY-STIMULATING FACTOR - A MULTICENTER PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 255-255
MONOTHERAPY WITH DOCETAXEL AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN ADVANCED GASTRIC-CANCER
Authors: ANDROULAKIS N KOUROUSIS C KAKOLYRIS S SARRA E KALBAKIS K KALIKAKI T KOIS S VARDAKIS N SAMONIS G GEORGOULIAS V
Citation: N. Androulakis et al., MONOTHERAPY WITH DOCETAXEL AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN ADVANCED GASTRIC-CANCER, Annals of oncology, 9, 1998, pp. 258-258
A MULTICENTER PHASE-II STUDY OF SINGLE-AGENT DOCETAXEL AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER PREVIOUSLY TREATED WITH PLATINUM-BASED CHEMOTHERAPY
Authors: PAPADAKIS E ALEXOPOULOS K ANDROULAKIS N KOUROUSIS C KAKOLYRIS S SAMELIS G PATILA E VOSSOS A SAMANTAS E GEORGOULIAS V
Citation: E. Papadakis et al., A MULTICENTER PHASE-II STUDY OF SINGLE-AGENT DOCETAXEL AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER PREVIOUSLY TREATED WITH PLATINUM-BASED CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 443-443
PHASE I II TRIAL OF DOCETAXEL (D) AND CARBOPLATIN (CBDCA) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC)/
Authors: GIANNAKAKIS T PAPADOURIS S KOUROUSIS C KALBAKIS NK TZIANNI V LIDAKI E ANDROULAKIS N SOUKLAKOS J SARRA E GEORGOULIAS V
Citation: T. Giannakakis et al., PHASE I II TRIAL OF DOCETAXEL (D) AND CARBOPLATIN (CBDCA) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC)/, Annals of oncology, 9, 1998, pp. 452-452
FRONT-LINE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER WITH DOCETAXEL AND GEMCITABINE - A MULTICENTER PHASE-II TRIAL
Authors: GEORGOULIAS V KOUROUSIS C KAKOLYRIS S DIMOPOULOS MA PAPADAKIS E APOSTOLOPULOU F AGELIDOU A TZIANNI V SARRA E VARDAKIS N
Citation: V. Georgoulias et al., FRONT-LINE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER WITH DOCETAXEL AND GEMCITABINE - A MULTICENTER PHASE-II TRIAL, Annals of oncology, 9, 1998, pp. 453-453
PHASE-I STUDY OF IRINOTECAN (CPT-11) AND CISPLATIN (CDDP) COMBINATIONIN METASTATIC NONSMALL CELL LUNG-CANCER (NSCLC)
Authors: KAKOLYRIS S KOUROUSSIS C SOUGLAKOS J ANDROULAKIS N MAVROUDIS D KALBAKIS K KOTSAKIS A SARA E AGELAKI S SAMONIS G GEORGOULIAS V
Citation: S. Kakolyris et al., PHASE-I STUDY OF IRINOTECAN (CPT-11) AND CISPLATIN (CDDP) COMBINATIONIN METASTATIC NONSMALL CELL LUNG-CANCER (NSCLC), Annals of oncology, 9, 1998, pp. 463-463
PHASE-I STUDY OF WEEKLY PLACLITAXEL IN ADVANCED SOLID TUMORS - A PRELIMINARY-REPORT
Authors: AGELAKI S MAVROUDIS D KAKOLYRIS S KOUROUSIS C KALBAKIS K SARRA E SOUGLAKOS J KALIKAKI T PERISINAKI G GEORGOULIAS V
Citation: S. Agelaki et al., PHASE-I STUDY OF WEEKLY PLACLITAXEL IN ADVANCED SOLID TUMORS - A PRELIMINARY-REPORT, Annals of oncology, 9, 1998, pp. 664-664
FIRST-LINE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER WITH DOCETAXEL AND CISPLATIN - A MULTICENTER PHASE-II STUDY
Authors: GEORGOULIAS V ANDROULAKIS N DIMOPOULOS AM KOUROUSIS C KAKOLYRIS S PAPADAKIS E APOSTOLOPOULOU F PAPADIMITRIOU C VOSSOS A AGELIDOU M HERAS P TZANNES S VLACHONICOLIS J MAVROMANOLAKIS E HATZIDAKI D
Citation: V. Georgoulias et al., FIRST-LINE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER WITH DOCETAXEL AND CISPLATIN - A MULTICENTER PHASE-II STUDY, Annals of oncology, 9(3), 1998, pp. 331-334
SALVAGE TREATMENT WITH PACLITAXEL AND GEMCITABINE FOR PATIENTS WITH NON-SMALL-CELL LUNG-CANCER AFTER CISPLATIN-BASED OR DOCETAXEL-BASED CHEMOTHERAPY - A MULTICENTER PHASE-II STUDY
Authors: ANDROULAKIS N KOUROUSSIS C KAKOLYRIS S TZANNES S PAPADAKIS E PAPADIMITRIOU C GEROYIANNI A GEORGOPOULOU T DIMOPOULOU I SOUGLAKOS J KOTSAKIS A VARDAKIS N HATZIDAKI D GEORGOULIAS V
Citation: N. Androulakis et al., SALVAGE TREATMENT WITH PACLITAXEL AND GEMCITABINE FOR PATIENTS WITH NON-SMALL-CELL LUNG-CANCER AFTER CISPLATIN-BASED OR DOCETAXEL-BASED CHEMOTHERAPY - A MULTICENTER PHASE-II STUDY, Annals of oncology, 9(10), 1998, pp. 1127-1130
TREATMENT OF NON-SMALL-CELL LUNG-CANCER WITH PROLONGED ORAL ETOPOSIDE
Authors: KAKOLYRIS S SAMONIS G KOUKOURAKIS M VLACHONICOLIS I CHALKIADAKIS G KALBAKIS K SOUGLAKOS I AGELAKI S TOLOUDIS P GEORGOULIAS V
Citation: S. Kakolyris et al., TREATMENT OF NON-SMALL-CELL LUNG-CANCER WITH PROLONGED ORAL ETOPOSIDE, American journal of clinical oncology, 21(5), 1998, pp. 505-508
SALVAGE CHEMOTHERAPY WITH PACLITAXEL, VINORELBINE, AND CISPLATIN (PVC) IN ANTHRACYCLINE-RESISTANT ADVANCED BREAST-CANCER
Authors: KOUROUSIS C KAKOLYRIS S ANDROULAKIS N HERAS P VLACHONICOLIS J VAMVAKAS L VLATA M HATZIDAKI D SAMONIS G GEORGOULIAS V
Citation: C. Kourousis et al., SALVAGE CHEMOTHERAPY WITH PACLITAXEL, VINORELBINE, AND CISPLATIN (PVC) IN ANTHRACYCLINE-RESISTANT ADVANCED BREAST-CANCER, American journal of clinical oncology, 21(3), 1998, pp. 226-232
EXPRESSION OF P53, P21, MDM2, RB, BAX AND KI67 PROTEINS IN LYMPHOMAS OF THE MUCOSA-ASSOCIATED LYMPHOID (MALT) TISSUE
Authors: STEFANAKI K TZARDI M KOUVIDOU C CHANIOTIS V BOLIOTI M VLYCHOU M ZOIS M KAKOLYRIS S DELIDES G RONTOGIANNI D GEORGOULIAS V KANAVAROS P
Citation: K. Stefanaki et al., EXPRESSION OF P53, P21, MDM2, RB, BAX AND KI67 PROTEINS IN LYMPHOMAS OF THE MUCOSA-ASSOCIATED LYMPHOID (MALT) TISSUE, Anticancer research, 18(4A), 1998, pp. 2403-2408
IMMUNOHISTOCHEMICAL DETECTION OF BCL2, P53, MDM2 AND P2L WAF1 PROTEINS IN SMALL-CELL LUNG CARCINOMAS/
Authors: STEFANAKI K RONTOGIANNIS D VAMVOUKA C BOLIOTI S CHANIOTIS V SOTSIOU F VLYCHOU M DELIDIS G KAKOLYRIS S GEORGOULIAS V KANAVAROS P
Citation: K. Stefanaki et al., IMMUNOHISTOCHEMICAL DETECTION OF BCL2, P53, MDM2 AND P2L WAF1 PROTEINS IN SMALL-CELL LUNG CARCINOMAS/, Anticancer research, 18(3A), 1998, pp. 1689-1695
IMMUNOHISTOCHEMICAL DETECTION OF BCL2, P53, MDM2 AND P21 WAF1 PROTEINS IN SMALL-CELL LUNG CARCINOMAS/
Authors: STEFANAKI K RONTOGIANNIS D VAMVOUKA C BOLIOTI S CHANIOTIS V SOTSIOU F VLYCHOU M DELIDIS G KAKOLYRIS S GEORGOULIAS V KANAVAROS P
Citation: K. Stefanaki et al., IMMUNOHISTOCHEMICAL DETECTION OF BCL2, P53, MDM2 AND P21 WAF1 PROTEINS IN SMALL-CELL LUNG CARCINOMAS/, Anticancer research, 18(2A), 1998, pp. 1167-1173
COMBINATION CHEMOTHERAPY WITH DOCETAXEL, VINORELBINE AND CISPLATIN ASFIRST-LINE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A MULTICENTER PHASE-II STUDY OF THE GREEK COOPERATIVE GROUP FOR LUNG-CANCER
Authors: GEORGOULIAS V ANDROULAKIS N BOUROS D KOUROUSSIS C CHATZAKIS K PAPADAKIS M APOSTOPOLOULOU F GEORGEPOULOU T KOTSAKIS T SOUKLAKOS J HATZIDAKI D VLACHONIKOLIS J PANAGOS G
Citation: V. Georgoulias et al., COMBINATION CHEMOTHERAPY WITH DOCETAXEL, VINORELBINE AND CISPLATIN ASFIRST-LINE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A MULTICENTER PHASE-II STUDY OF THE GREEK COOPERATIVE GROUP FOR LUNG-CANCER, Lung cancer, 21(3), 1998, pp. 213-220
MORTALITY FROM MALIGNANT NEOPLASMS IN CRETE, 1992-1993
Authors: VLACHONIKOLIS IG PHILALITHIS AE BRITTAN Y GEORGOULIAS V
Citation: Ig. Vlachonikolis et al., MORTALITY FROM MALIGNANT NEOPLASMS IN CRETE, 1992-1993, Journal of epidemiology and community health, 52(2), 1998, pp. 126-127
Risultati: 1-25 | 26-50